SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 83 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2014. The put-call ratio across all filers is 2.83 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $112,000 | -38.5% | 64,476 | -21.1% | 0.11% | -32.1% |
| Q2 2015 | $182,000 | +65.5% | 81,694 | +44.5% | 0.16% | +54.2% |
| Q1 2015 | $110,000 | -49.5% | 56,518 | -31.4% | 0.11% | -49.0% |
| Q4 2014 | $218,000 | -14.2% | 82,383 | -2.6% | 0.21% | -26.6% |
| Q3 2014 | $254,000 | -37.3% | 84,606 | -14.6% | 0.29% | -35.1% |
| Q2 2014 | $405,000 | -11.2% | 99,023 | -3.9% | 0.44% | -5.8% |
| Q1 2014 | $456,000 | -8.8% | 103,021 | +8.0% | 0.47% | -14.3% |
| Q4 2013 | $500,000 | – | 95,361 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 30,197,945 | $80,025,000 | 92.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 457,458 | $1,212,000 | 0.22% |
| Verity Asset Management, Inc. | 82,383 | $218,000 | 0.21% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,238 | $880,000 | 0.12% |
| Cutler Capital Management, LLC | 62,500 | $165,000 | 0.07% |
| Capital Impact Advisors, LLC | 37,788 | $100,000 | 0.05% |
| SECOR Capital Advisors, LP | 35,087 | $93,000 | 0.04% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 50,814 | $134,000 | 0.04% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |